Unlocking the Potential of CTF18-Replication Factor C Complex: A Potential Drug Target and Biomarker

Target Name: CTF18-replication factor C complex

NCBI ID: P16333

CTF18-replication factor C complex

Other Name(s): CTF18-replication factor C | CTF18-RFC

Unlocking the Potential of CTF18-Replication Factor C Complex: A Potential Drug Target and Biomarker

Introduction

The replication factor C complex (CTF18-replication factor C) plays a crucial role in the regulation of DNA replication in various organisms, including humans. It is a protein that contains several subunits, including C1, C2, C3, and C4, which work together to ensure the proper formation of double-stranded DNA during the replication process. The C complex is also known as the C-replication complex, and it is composed of various proteins that help to recruit and organize the necessary components for DNA replication.

Recent studies have identified CTF18-replication factor C as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and genetic disorders. In this article, we will delve into the research on CTF18-replication factor C and its potential as a drug target and biomarker.

The Importance of CTF18-replication factor C

CTF18-replication factor C is a critical protein that helps ensure the proper functioning of DNA replication. It plays a vital role in the regulation of the timing and order of the recruitment of the necessary components for DNA replication. C1, C2, C3, and C4, the subunits of the C complex, work together to recruit the necessary proteins and RNA factors for DNA replication, as well as to ensure the proper organization of the replication complex.

Research has shown that CTF18-replication factor C is involved in various cellular processes, including cell division, DNA replication, and transcription. It has been shown to play a role in the regulation of cell cycle progression, and it has been linked to the development and progression of various diseases.

As a Potential Drug Target

The potential use of CTF18-replication factor C as a drug target is based on its involvement in various cellular processes and its potential role in the development of various diseases. Several studies have shown that targeting CTF18-replication factor C may be an effective way to treat various diseases, including cancer, neurodegenerative diseases, and genetic disorders.

One of the main reasons for the potential use of CTF18-replication factor C as a drug target is its involvement in the regulation of DNA replication. Many diseases, including cancer, are caused by disruptions in DNA replication. By targeting CTF18-replication factor C , researchers may be able to reduce the risk of DNA replication errors and improve the effectiveness of cancer treatments.

Another potential use of CTF18-replication factor C as a drug target is its role in the development of neurodegenerative diseases. The C complex plays a crucial role in the regulation of DNA replication, and disruptions in this process have been linked to the development of neurodegenerative diseases. diseases. Targeting CTF18-replication factor C may be an effective way to treat neurodegenerative diseases and improve treatment outcomes.

In addition to its potential role in the regulation of DNA replication, CTF18-replication factor C has also been shown to play a role in the regulation of transcription. This suggests that it may be involved in the development of various diseases, including genetic disorders.

As a Potential Biomarker

The potential use of CTF18-replication factor C as a biomarker is based on its involvement in various cellular processes and its potential to be used as a diagnostic tool for various diseases. Several studies have shown that the levels of CTF18-replication factor C are involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.

Research has also shown that changes in the levels of CTF18-replication factor C are involved in the development

Protein Name: CTF18-replication Factor C Complex

The "CTF18-replication factor C complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CTF18-replication factor C complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets